Recordati reported EUR199.38M in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Almirall EUR 199.26M 7.76M Jun/2026
GlaxoSmithKline GBP 2.07B 192M Jun/2026
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Orion EUR 181.7M 18M Jun/2026
Sanofi EUR 3.02B 656M Jun/2026